Laboratorio di Fisiopatologia Ortopedica e Medicina Rigenerativa, Istituto Ortopedico Rizzoli, via di Barbiano 1/10, I-40136 Bologna, Italy.
Eur J Med Chem. 2013 Jul;65:448-55. doi: 10.1016/j.ejmech.2013.04.032. Epub 2013 May 11.
Bisphosphonates (BPs) are key drugs for the treatment of bone resorption diseases like osteoporosis, Paget's disease and some forms of tumors. Recent findings underlined the importance of lipophilic N-containing BPs to ensure high biological activity. Herein we present some unprecedented results concerning the low toxicity and good anti-osteoclast activity of low molecular weight hydrophilic S-containing BPs. A series of S and N-containing BPs bearing aromatic and aliphatic substitution were prepared through Michael addition reaction between vinylidenebisphosphonate tetraethyl ester and the proper nucleophile under basic catalysis. S-containing BPs showed a generally low toxicity, determined with the neutral-red assay using the L929 cell line, and, in particular for an aliphatic one, a good biological activity assessed on primary cultures of human osteoclasts.
双膦酸盐(BPs)是治疗骨质疏松症、佩吉特病和某些形式的肿瘤等骨吸收疾病的关键药物。最近的研究结果强调了亲脂性含氮 BPs 的重要性,以确保高生物活性。在此,我们介绍了一些前所未有的关于低分子量亲水性含硫 BPs 低毒性和良好抗破骨细胞活性的结果。通过在碱性催化下,将亚乙烯基二膦酸四乙酯与适当的亲核试剂进行迈克尔加成反应,制备了一系列带有芳香族和脂肪族取代基的 S 和 N 含 BPs。用 L929 细胞系进行中性红试验测定 S 含 BPs 的一般低毒性,特别是对于一种脂肪族 S 含 BPs,用人原代破骨细胞培养物评估其良好的生物学活性。